๐ฆ Actinomyces israelii infection (actinomycosis) is a chronic suppurative disease that produces multiple abscesses and sinus tracts, often with discharge of characteristic yellow "sulfur granules" ๐พ.
About
- ๐จโโ๏ธ First described by German surgeon James Adolf Israel in the 19th century.
- ๐งซ Pathogen: Actinomyces israelii โ a Gram-positive anaerobic bacterium, part of normal oral and gut flora.
- ๐ฉบ Infection arises when mucosal barriers are disrupted (e.g. dental extraction, surgery, IUD insertion).
Characteristics
- ๐ฌ Gram-positive, branching, filamentous, nonโacid-fast anaerobe.
- ๐พ Forms dense colonies producing sulfur granules, which are pathognomonic.
- ๐ญ Often mimics malignancy due to invasive, destructive growth across tissue planes.
Aetiology
- โก Opportunistic infection: Occurs in devitalised or traumatised tissue.
- ๐ฆ Main pathogen: Actinomyces israelii.
- ๐ฆท Common associations: poor oral hygiene, dental trauma, or long-term IUD use.
Clinical Features
- ๐ Cervicofacial actinomycosis ("lumpy jaw"):
- ๐ฆท Follows dental trauma or poor oral hygiene.
- ๐ Firm, painless swelling with multiple draining sinuses discharging sulfur granules.
- ๐ซ Thoracic actinomycosis:
- Caused by aspiration, leading to lung/mediastinal abscesses.
- ๐ง Brain abscesses:
- Neurological deficits due to space-occupying lesions.
- ๐ฉป Abdominal/Pelvic actinomycosis:
- Often post-IUD insertion; pelvic pain, mass effect, chronic inflammation.
- ๐ฅ May mimic malignancy; fistulas and abscesses are common.
- Symptoms: abdominal pain, weight loss, fever, palpable mass.
๐งช Investigations
- ๐ Bloods: FBC may show anaemia of chronic disease, โWCC, raised ESR/CRP.
- ๐ฉป CXR: Cavitating, pleural-based, or mass-like lesions in thoracic actinomycosis; can mimic TB or lung cancer.
- ๐ฅ๏ธ Ultrasound/CT: Useful for abdominal/pelvic masses; helps detect fistulae or abscess spread across tissue planes.
- ๐ฌ Histology: โSulphur granulesโ (yellow colonies) on microscopy are highly suggestive.
- ๐ฅผ Culture: Anaerobic culture of pus/granules confirms diagnosis, but slow growth (may take 2โ3 weeks).
๐ Management
- ๐ High-dose Penicillin G: First-line; usually IV for 2โ6 weeks, then oral penicillin/amoxicillin for several months (total 6โ12 months).
- ๐ Alternatives: Doxycycline, erythromycin, or clindamycin in penicillin-allergic patients (check BNF/local guidelines).
- ๐ช Surgery: Indicated for abscess drainage, fistula excision, or where malignancy is suspected (as Actinomyces can mimic tumours on imaging).
- ๐ฉบ Follow-up: Long-term clinical and radiological monitoring needed, as relapse is common if treatment is stopped prematurely.